Bosh sahifaDMN • FRA
add
Diamyd Medical AB
Yopilish kursi
0,72 €
Kunlik diapazon
0,80 € - 0,80 €
Yillik diapazon
0,65 € - 1,78 €
Bozor kapitalizatsiyasi
1,28 mlrd SEK
Oʻrtacha hajm
1,00
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
STO
Bozor yangiliklari
Barron's
2 kun oldin
Berkshire Stock Could Drop 99% and Still Top S&P 500 Over Buffett’s 60-Year Reign
1,81%
1,47%
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (SEK) | fev, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 86,00 ming | 230,77% |
Joriy xarajat | 44,69 mln | 59,86% |
Sof foyda | -44,87 mln | -53,39% |
Sof foyda marjasi | -52,17 ming | 53,63% |
Har bir ulushga tushum | — | — |
EBITDA | -44,01 mln | -60,78% |
Amaldagi soliq stavkasi | — | — |
Balans
Jami aktivlari
Jami passivlari
| (SEK) | fev, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 103,75 mln | -24,35% |
Jami aktivlari | 180,88 mln | -20,13% |
Jami passivlari | 69,35 mln | 53,23% |
Umumiy kapital | 111,53 mln | — |
Tarqatilgan aksiyalar | 104,09 mln | — |
Narxi/balansdagi bahosi | 0,67 | — |
Aktivlardan daromad | — | — |
Kapitaldan daromad | — | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (SEK) | fev, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -44,87 mln | -53,39% |
Operatsiyalardan naqd pul | -48,41 mln | -36,64% |
Sarmoyadan naqd pul | -458,00 ming | 86,82% |
Moliyadan naqd pul | -635,00 ming | -203,83% |
Naqd pulning sof oʻzgarishi | -49,13 mln | -24,15% |
Boʻsh pul | -32,72 mln | -9,70% |
Haqida
Diamyd Medical AB is a small biotechnology company headquartered in Stockholm, Sweden that focuses on immune modifying therapies for diabetes. The company is developing two products.
The company is headquartered in Stockholm, and maintains a manufacturing facility in Umeå. Wikipedia
Tashkil etilgan
1984
Sayt
Xodimlar soni
30
